UniProt ID | CACO1_HUMAN | |
---|---|---|
UniProt AC | Q9P1Z2 | |
Protein Name | Calcium-binding and coiled-coil domain-containing protein 1 | |
Gene Name | CALCOCO1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 691 | |
Subcellular Localization | Cytoplasm. Nucleus. Shuttles between nucleus and cytoplasm.. | |
Protein Description | Functions as a coactivator for aryl hydrocarbon and nuclear receptors (NR). Recruited to promoters through its contact with the N-terminal basic helix-loop-helix-Per-Arnt-Sim (PAS) domain of transcription factors or coactivators, such as NCOA2. During ER-activation acts synergistically in combination with other NCOA2-binding proteins, such as EP300, CREBBP and CARM1. Involved in the transcriptional activation of target genes in the Wnt/CTNNB1 pathway. Functions as a secondary coactivator in LEF1-mediated transcriptional activation via its interaction with CTNNB1. Coactivator function for nuclear receptors and LEF1/CTNNB1 involves differential utilization of two different activation regions (By similarity). In association with CCAR1 enhances GATA1- and MED1-mediated transcriptional activation from the gamma-globin promoter during erythroid differentiation of K562 erythroleukemia cells. [PubMed: 24245781; Seems to enhance inorganic pyrphosphatase thus activating phosphogluomutase (PMG Probably functions as component of the calphoglin complex, which is involved in linking cellular metabolism (phosphate and glucose metabolism) with other core functions including protein synthesis and degradation, calcium signaling and cell growth.] | |
Protein Sequence | MEESPLSRAPSRGGVNFLNVARTYIPNTKVECHYTLPPGTMPSASDWIGIFKVEAACVRDYHTFVWSSVPESTTDGSPIHTSVQFQASYLPKPGAQLYQFRYVNRQGQVCGQSPPFQFREPRPMDELVTLEEADGGSDILLVVPKATVLQNQLDESQQERNDLMQLKLQLEGQVTELRSRVQELERALATARQEHTELMEQYKGISRSHGEITEERDILSRQQGDHVARILELEDDIQTISEKVLTKEVELDRLRDTVKALTREQEKLLGQLKEVQADKEQSEAELQVAQQENHHLNLDLKEAKSWQEEQSAQAQRLKDKVAQMKDTLGQAQQRVAELEPLKEQLRGAQELAASSQQKATLLGEELASAAAARDRTIAELHRSRLEVAEVNGRLAELGLHLKEEKCQWSKERAGLLQSVEAEKDKILKLSAEILRLEKAVQEERTQNQVFKTELAREKDSSLVQLSESKRELTELRSALRVLQKEKEQLQEEKQELLEYMRKLEARLEKVADEKWNEDATTEDEEAAVGLSCPAALTDSEDESPEDMRLPPYGLCERGDPGSSPAGPREASPLVVISQPAPISPHLSGPAEDSSSDSEAEDEKSVLMAAVQSGGEEANLLLPELGSAFYDMASGFTVGTLSETSTGGPATPTWKECPICKERFPAESDKDALEDHMDGHFFFSTQDPFTFE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MEESPLSRAPS ----CCCCCCCCCCC | 20.17 | 22199227 | |
7 | Phosphorylation | -MEESPLSRAPSRGG -CCCCCCCCCCCCCC | 29.76 | 23186163 | |
11 | Phosphorylation | SPLSRAPSRGGVNFL CCCCCCCCCCCCCCE | 42.44 | 29523821 | |
29 | Sumoylation | RTYIPNTKVECHYTL EEECCCCCEEEEEEC | 42.55 | - | |
29 | Sumoylation | RTYIPNTKVECHYTL EEECCCCCEEEEEEC | 42.55 | - | |
156 | Phosphorylation | LQNQLDESQQERNDL HHHHCCHHHHHHHHH | 36.51 | 28555341 | |
243 | Ubiquitination | DIQTISEKVLTKEVE HHHHHHHHHCCCHHH | 35.44 | - | |
247 | Ubiquitination | ISEKVLTKEVELDRL HHHHHCCCHHHHHHH | 56.45 | - | |
273 | Ubiquitination | EKLLGQLKEVQADKE HHHHHHHHHHHCCHH | 48.21 | - | |
325 | Malonylation | KDKVAQMKDTLGQAQ HHHHHHHHHHHHHHH | 35.17 | 26320211 | |
342 | Ubiquitination | VAELEPLKEQLRGAQ HHHHHHHHHHHHHHH | 54.88 | - | |
346 | Methylation | EPLKEQLRGAQELAA HHHHHHHHHHHHHHH | 37.79 | - | |
358 | Ubiquitination | LAASSQQKATLLGEE HHHHHHHHHHHHHHH | 35.38 | - | |
418 | Phosphorylation | ERAGLLQSVEAEKDK HHHCHHHHHHHHHHH | 23.15 | 24719451 | |
460 | Phosphorylation | ELAREKDSSLVQLSE HHHHHCCCCCHHHCH | 36.32 | 28634120 | |
461 | Phosphorylation | LAREKDSSLVQLSES HHHHCCCCCHHHCHH | 42.57 | 28634120 | |
466 | Phosphorylation | DSSLVQLSESKRELT CCCCHHHCHHHHHHH | 23.80 | 21815630 | |
468 | Phosphorylation | SLVQLSESKRELTEL CCHHHCHHHHHHHHH | 33.37 | 25627689 | |
477 | Phosphorylation | RELTELRSALRVLQK HHHHHHHHHHHHHHH | 44.26 | - | |
493 | Ubiquitination | KEQLQEEKQELLEYM HHHHHHHHHHHHHHH | 48.60 | - | |
531 | Phosphorylation | EEAAVGLSCPAALTD HHHHHCCCCCCCCCC | 16.48 | 28348404 | |
537 | Phosphorylation | LSCPAALTDSEDESP CCCCCCCCCCCCCCC | 32.52 | 28348404 | |
539 | Phosphorylation | CPAALTDSEDESPED CCCCCCCCCCCCCCC | 41.53 | 28348404 | |
562 | Phosphorylation | CERGDPGSSPAGPRE CCCCCCCCCCCCCCC | 38.24 | 29255136 | |
563 | Phosphorylation | ERGDPGSSPAGPREA CCCCCCCCCCCCCCC | 25.37 | 29255136 | |
571 | Phosphorylation | PAGPREASPLVVISQ CCCCCCCCCEEEEEC | 17.64 | - | |
650 | Phosphorylation | TSTGGPATPTWKECP CCCCCCCCCCCCCCC | 25.12 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CACO1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CACO1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SH3G3_HUMAN | SH3GL3 | physical | 16169070 | |
EP300_HUMAN | EP300 | physical | 16717280 | |
CTNB1_HUMAN | CTNNB1 | genetic | 16931570 | |
EP300_HUMAN | EP300 | physical | 16931570 | |
A4_HUMAN | APP | physical | 21832049 | |
GRIK2_HUMAN | GRIK2 | physical | 21988832 | |
TBC15_HUMAN | TBC1D15 | physical | 25416956 | |
F161A_HUMAN | FAM161A | physical | 25416956 | |
CEP19_HUMAN | CEP19 | physical | 25416956 | |
C19L2_HUMAN | CWF19L2 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...